NASDAQ:CRNC

Cerence (CRNC) Stock Price, News & Analysis

$5.10
-0.25 (-4.67%)
(As of 05/13/2024 ET)
Today's Range
$5.02
$5.39
50-Day Range
$5.35
$15.75
52-Week Range
$5.01
$36.79
Volume
2.93 million shs
Average Volume
590,675 shs
Market Capitalization
$212.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.08

Cerence MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
97.7% Upside
$10.08 Price Target
Short Interest
Bearish
18.14% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.68
Upright™ Environmental Score
News Sentiment
0.30mentions of Cerence in the last 14 days
Based on 18 Articles This Week
Insider Trading
Selling Shares
$585,912 Sold Last Quarter
Proj. Earnings Growth
-92.59%
From $0.54 to $0.04 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.99 out of 5 stars

Computer And Technology Sector

201st out of 599 stocks

Prepackaged Software Industry

68th out of 203 stocks

CRNC stock logo

About Cerence Stock (NASDAQ:CRNC)

Cerence Inc. provides AI powered virtual assistants for the mobility/transportation market in United States, Other Americas, Germany, Europe, Middle East, Africa, Japan, and Other Asia-Pacific. The company offers edge software components, cloud-connected components, virtual assistant coexistence, and professional services. It also provides conversational artificial intelligence-based solutions, including speech recognition, natural language understanding, speech signal enhancement, text-to-speech, and acoustic modeling technology. Cerence Inc. is headquartered in Burlington, Massachusetts.

CRNC Stock Price History

CRNC Stock News Headlines

Wells Fargo Downgrades Cerence (CRNC)
Wedbush Reaffirms Their Hold Rating on Cerence (CRNC)
What Analysts Are Saying About Cerence Stock
Needham Downgrades Cerence (CRNC)
Analyst Scoreboard: 4 Ratings For Cerence
3 Tech Stocks to Buy to Triple Your Investment by 2025
CRNC Apr 2024 15.000 put
CRNC Apr 2024 20.000 call
See More Headlines
Receive CRNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerence and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/27/2023
Today
5/13/2024
Next Earnings (Estimated)
8/13/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CRNC
Fax
N/A
Employees
1,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.08
High Stock Price Target
$23.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+92.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

Net Income
$-56,250,000.00
Pretax Margin
-63.47%

Debt

Sales & Book Value

Annual Sales
$294.48 million
Book Value
$17.23 per share

Miscellaneous

Free Float
41,179,000
Market Cap
$218.35 million
Optionable
Optionable
Beta
2.57
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. Stefan  OrtmannsDr. Stefan Ortmanns (Age 60)
    President, CEO & Director
    Comp: $1.18M
  • Mr. Iqbal Arshad (Age 62)
    Executive VP & CTO
    Comp: $906.7k
  • Mr. Thomas L. Beaudoin (Age 71)
    Executive Officer & Director
    Comp: $868.08k
  • Mr. Daniel D. Tempesta (Age 54)
    Chief Financial Officer
  • Ms. Jennifer Salinas
    Senior VP, General Counsel & Secretary
  • Mr. Sachin Sahney
    Chief Human Resources Officer
  • Mr. Sujal Shah
    Head of Professional Services
  • Mr. Nils Schanz
    Chief Product Officer
  • Mr. Christian Mentz
    Chief Revenue Officer
  • Dennis J. Close
    VP & Treasurer

CRNC Stock Analysis - Frequently Asked Questions

Should I buy or sell Cerence stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cerence in the last year. There are currently 6 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CRNC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRNC, but not buy additional shares or sell existing shares.
View CRNC analyst ratings
or view top-rated stocks.

What is Cerence's stock price target for 2024?

6 equities research analysts have issued 12 month price targets for Cerence's shares. Their CRNC share price targets range from $6.00 to $23.00. On average, they expect the company's share price to reach $10.08 in the next twelve months. This suggests a possible upside of 97.7% from the stock's current price.
View analysts price targets for CRNC
or view top-rated stocks among Wall Street analysts.

How have CRNC shares performed in 2024?

Cerence's stock was trading at $19.66 at the beginning of 2024. Since then, CRNC stock has decreased by 74.1% and is now trading at $5.10.
View the best growth stocks for 2024 here
.

When is Cerence's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024.
View our CRNC earnings forecast
.

How were Cerence's earnings last quarter?

Cerence Inc. (NASDAQ:CRNC) released its quarterly earnings results on Monday, November, 27th. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by $0.06. The business earned $80.80 million during the quarter, compared to analyst estimates of $74.37 million. Cerence had a negative net margin of 80.93% and a positive trailing twelve-month return on equity of 3.66%. Cerence's revenue was up 39.1% on a year-over-year basis. During the same quarter last year, the company posted ($0.27) EPS.

What guidance has Cerence issued on next quarter's earnings?

Cerence issued an update on its third quarter 2024 earnings guidance on Thursday, May, 9th. The company provided earnings per share (EPS) guidance of -0.010-0.130 for the period, compared to the consensus EPS estimate of 0.130. The company issued revenue guidance of $66.0 million-$72.0 million, compared to the consensus revenue estimate of $75.5 million.

What other stocks do shareholders of Cerence own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cerence investors own include NVIDIA (NVDA), Block (SQ), Fastly (FSLY), DocuSign (DOCU), PayPal (PYPL), Shopify (SHOP), Teladoc Health (TDOC), Alteryx (AYX), Lumentum (LITE) and Salesforce (CRM).

Who are Cerence's major shareholders?

Cerence's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (12.79%), Pinnacle Associates Ltd. (1.49%), Mirae Asset Global Investments Co. Ltd. (0.86%), Principal Financial Group Inc. (0.52%), Sei Investments Co. (0.22%) and Susquehanna Fundamental Investments LLC (0.21%). Insiders that own company stock include Christophe Couvreur, Iqbal Arshad, Leanne Fitzgerald, Mark J Gallenberger, Prateek Kathpal, Sanjay Dhawan, Stefan Ortmanns and Thomas L Beaudoin.
View institutional ownership trends
.

How do I buy shares of Cerence?

Shares of CRNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CRNC) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners